A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Experimental Drug Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to contact these accounts privately for source information, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a flourishing market exists on Telegram, where groups with numerous of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an experimental injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Concerns
However, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.
Several professionals said the demand for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Content Elimination
Based on TikTok, the service has taken down problematic content and prohibited related keywords and query recommendations. The company stated it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with numerous of users, filled with images of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
After minutes of joining one community, a vendor shared contact information, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.
Item Details and Costs
Inside these communities, posts display black plastic packages with postal service stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When questioned how much time a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram said it actively monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering materials they cannot confirm. Although the research behind retatrutide is valid, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.
Her team has already encountered individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose users to potentially significant medical dangers”.
